CN101490245B - 无血清培养基及其在软骨细胞扩增中的用途 - Google Patents
无血清培养基及其在软骨细胞扩增中的用途 Download PDFInfo
- Publication number
- CN101490245B CN101490245B CN2007800274495A CN200780027449A CN101490245B CN 101490245 B CN101490245 B CN 101490245B CN 2007800274495 A CN2007800274495 A CN 2007800274495A CN 200780027449 A CN200780027449 A CN 200780027449A CN 101490245 B CN101490245 B CN 101490245B
- Authority
- CN
- China
- Prior art keywords
- cells
- cell
- osm
- serum
- chondrocytes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0655—Chondrocytes; Cartilage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/237—Oncostatin M [OSM]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/74—Alginate
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80530706P | 2006-06-20 | 2006-06-20 | |
| US60/805,307 | 2006-06-20 | ||
| PCT/US2007/014075 WO2007149328A1 (en) | 2006-06-20 | 2007-06-15 | Serum-free media and their uses for chondrocyte expansion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101490245A CN101490245A (zh) | 2009-07-22 |
| CN101490245B true CN101490245B (zh) | 2013-01-16 |
Family
ID=38626563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007800274495A Active CN101490245B (zh) | 2006-06-20 | 2007-06-15 | 无血清培养基及其在软骨细胞扩增中的用途 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20070292949A1 (https=) |
| EP (1) | EP2032689A1 (https=) |
| JP (1) | JP2009540826A (https=) |
| CN (1) | CN101490245B (https=) |
| AU (1) | AU2007261530B2 (https=) |
| BR (1) | BRPI0713572A2 (https=) |
| IL (1) | IL196025A (https=) |
| MX (1) | MX2008016429A (https=) |
| WO (1) | WO2007149328A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8889127B2 (en) | 2004-07-01 | 2014-11-18 | Icahn School Of Medicine At Mount Sinai | Targeted protein replacement for the treatment of lysosomal storage disorders |
| SI2132562T1 (sl) | 2007-04-06 | 2012-05-31 | Genzyme Corp | Metode za ovrednotenje celic in celičnih kultur |
| CN102411484B (zh) * | 2010-09-20 | 2015-01-28 | 联想(北京)有限公司 | 一种显示系统中的图像显示方法和装置 |
| KR101138091B1 (ko) * | 2011-08-31 | 2012-04-24 | 세원셀론텍(주) | 중간엽 줄기세포 기본 배양 배지 조성방법, 중간엽 줄기세포 기본 배양 배지 및 이를 이용하여 배양분화된 세포치료제 |
| LT2753346T (lt) | 2011-09-07 | 2020-08-10 | Mount Sinai School Of Medicine | Ceramidazė ir ląstelių diferenciacija |
| ES2897825T3 (es) | 2012-06-01 | 2022-03-02 | Icahn School Med Mount Sinai | Niveles de ceramida en el tratamiento y prevención de infecciones |
| US9664671B2 (en) | 2012-07-24 | 2017-05-30 | Nissan Chemical Industries, Ltd. | Culture medium composition and method of culturing cell or tissue using thereof |
| US10017805B2 (en) | 2012-08-23 | 2018-07-10 | Nissan Chemical Industries, Ltd. | Enhancing ingredients for protein production from various cells |
| CN104781389B (zh) * | 2012-08-23 | 2018-05-29 | 日产化学工业株式会社 | 蛋白质生产促进剂 |
| US8835175B2 (en) * | 2012-11-13 | 2014-09-16 | Grifols, S.A. | Culture medium for human mesenchymal stem cells |
| EP2733200A1 (en) | 2012-11-15 | 2014-05-21 | Biorigen International SA | Cell culture supplements |
| PT2968479T (pt) | 2013-03-14 | 2019-08-07 | Icahn School Med Mount Sinai | Composições terapêuticas de ceramidase ácida e métodos de fabrico e utilização |
| WO2015016357A1 (ja) * | 2013-08-01 | 2015-02-05 | 株式会社ツーセル | 軟骨損傷治療剤及びその製造方法 |
| CN104630138B (zh) * | 2013-11-06 | 2017-11-14 | 陕西瑞盛生物科技有限公司 | 一种无血清软骨细胞培养液 |
| JP2016067312A (ja) * | 2014-09-30 | 2016-05-09 | 株式会社ジーシー | 軟骨分化培養液、及び軟骨組織 |
| WO2016076102A1 (ja) * | 2014-11-14 | 2016-05-19 | 株式会社リジェネシスサイエンス | 軟骨細胞の無血清培養方法,及び無血清培地 |
| CN107849529A (zh) * | 2014-12-31 | 2018-03-27 | 迈克尔·莫勒 | 用于人脂肪基质细胞临床生长的细胞培养基的人血清 |
| CN108295243A (zh) * | 2018-02-27 | 2018-07-20 | 上海中医药大学附属龙华医院 | 可溶性Jagged1肽在制备促进关节软骨修复的药物中的应用 |
| CN109022356A (zh) * | 2018-08-30 | 2018-12-18 | 丰泽康生物医药(深圳)有限公司 | 一种提高间充质干细胞向软骨细胞分化的无血清培养基 |
| PH12021552425A1 (en) * | 2019-03-29 | 2022-07-11 | Kolon Tissuegene Inc | Mixed-cell gene therapy |
| CN111019887A (zh) * | 2019-11-11 | 2020-04-17 | 浙江卫未生物医药科技有限公司 | 阻止软骨细胞去分化的培育方法 |
| CN113215085B (zh) * | 2021-05-07 | 2024-05-10 | 澳门大学 | 一种脂类物质添加剂及其应用 |
| CN113106066B (zh) * | 2021-05-13 | 2022-08-23 | 杭州艾名医学科技有限公司 | 一种肉瘤细胞培养基以及采用该培养基体外生产Matrigel原液的方法 |
| US11692167B2 (en) | 2021-08-02 | 2023-07-04 | Montana State University | Chemically defined serum replacements for cell culture |
| WO2025117331A1 (en) | 2023-12-01 | 2025-06-05 | Eli Lilly And Company | Methods of making stem cell-derived islet-like cells, as well as populations and compositions including the same |
| CN118909927B (zh) * | 2024-09-12 | 2025-09-12 | 上海多宁生物科技股份有限公司 | 一种高表达的cho细胞培养方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997033978A1 (en) * | 1996-03-12 | 1997-09-18 | Life Technologies, Inc. | Hematopoietic cell culture nutrient supplement |
| WO2003064598A2 (en) * | 2002-01-25 | 2003-08-07 | Genzyme Corporation | Serum-free media for chondrocytes and methods of use thereof |
| US6635802B1 (en) * | 2000-01-10 | 2003-10-21 | The Texas A&M University System | Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT87133B (pt) * | 1987-04-02 | 1992-07-31 | Amrad Corp Ltd | Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif |
| US5202116A (en) * | 1989-04-10 | 1993-04-13 | Oncogen | Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
| US5814307A (en) * | 1989-04-10 | 1998-09-29 | Bristol-Myers Squibb Company | Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6 |
| US5843892A (en) * | 1989-12-18 | 1998-12-01 | California Institute Of Technology | Stimulation of nerve growth and/or vitality |
| US5188828A (en) * | 1990-11-08 | 1993-02-23 | Brigham And Women's Hospital | Interleukin-6 to stimulate erythropoietin production |
| AU2882992A (en) * | 1991-11-06 | 1993-06-07 | Arthur A. Axelrad | Cell culture medium |
| US5908782A (en) * | 1995-06-05 | 1999-06-01 | Osiris Therapeutics, Inc. | Chemically defined medium for human mesenchymal stem cells |
| WO1998004681A2 (en) * | 1996-07-25 | 1998-02-05 | Genzyme Corporation | Chondrocyte media formulations and culture procedures |
| US5945337A (en) * | 1996-10-18 | 1999-08-31 | Quality Biological, Inc. | Method for culturing CD34+ cells in a serum-free medium |
| US6156729A (en) * | 1997-10-15 | 2000-12-05 | California Institute Of Technology | Leukemia inhibitory factor for use in modulating inflammation and pain |
| JP2000319250A (ja) * | 1998-04-03 | 2000-11-21 | Sankyo Co Ltd | スルホンアミド誘導体 |
| CA2348687A1 (en) * | 1998-11-09 | 2000-05-18 | Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate | Serum free medium for chondrocyte-like cells |
| US20030202977A1 (en) * | 1998-11-16 | 2003-10-30 | New York University | Treatment of osteoarthritis |
| JP2001089390A (ja) * | 1999-09-16 | 2001-04-03 | Sumitomo Pharmaceut Co Ltd | 軟骨障害治療剤の新規なスクリーニング方法 |
| JP2001163885A (ja) * | 1999-09-29 | 2001-06-19 | Sankyo Co Ltd | スルホンアミド誘導体 |
| US7005252B1 (en) * | 2000-03-09 | 2006-02-28 | Wisconsin Alumni Research Foundation | Serum free cultivation of primate embryonic stem cells |
| EP1326980B1 (en) * | 2000-10-16 | 2008-03-19 | Genentech, Inc. | Methods of treatment using wisp polypeptides |
| PT1364023E (pt) * | 2000-12-08 | 2006-10-31 | Genentech Inc | Gene altamente expresso em tecidos de cartilagem |
| JP2002284686A (ja) * | 2001-03-28 | 2002-10-03 | Sankyo Co Ltd | スルホンアミド化合物を含有する医薬組成物 |
| AU2003222043A1 (en) * | 2002-03-18 | 2003-10-08 | National Jewish Medical And Research Center | Method for production of neutrophils and uses therefor |
| JP2006522453A (ja) * | 2003-03-31 | 2006-09-28 | リットン・システムズ・インコーポレイテッド | マイクロチャネルプレートの接合方法 |
| DK1656130T3 (da) * | 2003-08-11 | 2008-11-24 | Hills Pet Nutrition Inc | Omega-3-fedtsyrer til behandling af osteoarthritis hos hunde |
| JP2007536936A (ja) * | 2004-05-14 | 2007-12-20 | ベクトン・ディキンソン・アンド・カンパニー | 幹細胞集団および使用方法 |
| US7615374B2 (en) * | 2007-09-25 | 2009-11-10 | Wisconsin Alumni Research Foundation | Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions |
-
2007
- 2007-06-15 US US11/763,587 patent/US20070292949A1/en not_active Abandoned
- 2007-06-15 AU AU2007261530A patent/AU2007261530B2/en not_active Ceased
- 2007-06-15 BR BRPI0713572-6A patent/BRPI0713572A2/pt not_active IP Right Cessation
- 2007-06-15 JP JP2009516524A patent/JP2009540826A/ja active Pending
- 2007-06-15 CN CN2007800274495A patent/CN101490245B/zh active Active
- 2007-06-15 EP EP07809587A patent/EP2032689A1/en not_active Withdrawn
- 2007-06-15 WO PCT/US2007/014075 patent/WO2007149328A1/en not_active Ceased
- 2007-06-15 MX MX2008016429A patent/MX2008016429A/es active IP Right Grant
-
2008
- 2008-12-18 IL IL196025A patent/IL196025A/en not_active IP Right Cessation
-
2012
- 2012-02-21 US US13/401,037 patent/US20120213745A1/en not_active Abandoned
-
2013
- 2013-04-16 US US13/864,149 patent/US20130273010A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997033978A1 (en) * | 1996-03-12 | 1997-09-18 | Life Technologies, Inc. | Hematopoietic cell culture nutrient supplement |
| US6635802B1 (en) * | 2000-01-10 | 2003-10-21 | The Texas A&M University System | Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors |
| WO2003064598A2 (en) * | 2002-01-25 | 2003-08-07 | Genzyme Corporation | Serum-free media for chondrocytes and methods of use thereof |
Non-Patent Citations (1)
| Title |
|---|
| H. E. Barksby et al..nterleukin-1 in Combination With Oncostatin M Up-Regulates Multiple Genes in Chondrocytes.《ARTHRITIS & RHEUMATISM》.2006,第54卷(第2期),第541页右栏第2段、表1、第578页右栏第2段. * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2032689A1 (en) | 2009-03-11 |
| US20130273010A1 (en) | 2013-10-17 |
| MX2008016429A (es) | 2009-03-20 |
| CN101490245A (zh) | 2009-07-22 |
| AU2007261530A1 (en) | 2007-12-27 |
| AU2007261530B2 (en) | 2014-02-06 |
| IL196025A0 (en) | 2011-08-01 |
| WO2007149328A1 (en) | 2007-12-27 |
| JP2009540826A (ja) | 2009-11-26 |
| IL196025A (en) | 2014-12-31 |
| BRPI0713572A2 (pt) | 2012-10-23 |
| US20120213745A1 (en) | 2012-08-23 |
| US20070292949A1 (en) | 2007-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101490245B (zh) | 无血清培养基及其在软骨细胞扩增中的用途 | |
| Lin et al. | The chondrocyte: biology and clinical application | |
| US7169610B2 (en) | Serum-free media for chondrocytes and methods of use thereof | |
| WO2021254296A1 (zh) | 一种生物活性物质组合物、包含所述组合物的无血清培养基及其用途 | |
| JP2008500809A (ja) | インスリン産生細胞を発生させるための方法 | |
| US20070178074A1 (en) | Chondrocyte Culture Formulations | |
| AU2014297188A1 (en) | Cartilage-damage treatment agent and method for producing same | |
| Kisiday | Expansion of chondrocytes for cartilage tissue engineering: A review of chondrocyte dedifferentiation and redifferentiation as a function of growth in expansion culture | |
| CN101945993A (zh) | 使用生长因子组合的骨髓干细胞和间充质干细胞之骨生成分化 | |
| KR20110097064A (ko) | 무혈청 줄기 세포 배양 조성물, 이를 함유한 조직 재생용 조성물 및 이를 이용한 조직 재생 방법 | |
| JP4469371B2 (ja) | 脱分化型軟骨細胞の軟骨細胞への再分化用培地 | |
| US8431399B2 (en) | Method to restore cartilaginous phenotype of chondrocytes after cultured and expanded in vitro | |
| AU2014202438A1 (en) | Serum-Free Media and Their Uses for Chondrocyte Expansion | |
| KR102218126B1 (ko) | 소변 유래 줄기세포의 미분화능을 유지하는 방법 | |
| CN111676190B (zh) | 一种干细胞向成软骨分化的诱导剂及其应用 | |
| TWI477605B (zh) | 使體外繼代培養增生之軟骨細胞再度表現軟骨性表型之方法 | |
| CN119907675A (zh) | 一种椎间盘治疗剂 | |
| EP1780265A1 (en) | Differentiation of stem cells into chondrocytes | |
| AU2003205290A1 (en) | Serum-free media for chondrocytes and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |